Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03598777
What this trial is testing

Dysport in Vulvodynia Phase II Study

Who this might be right for
Vulvodynia
Ipsen 60
Early research (Phase 1)WithdrawnNCT01676675
What this trial is testing

A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults

Who this might be right for
Healthy
Jiangsu Province Centers for Disease Control and Prevention
Early research (Phase 1)Study completedNCT05580003
What this trial is testing

Learn Safety and Blood Levels of PF-07817883 in Healthy People

Who this might be right for
Healthy
Pfizer 94
Early research (Phase 1)Study completedNCT00506805
What this trial is testing

Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies

Who this might be right for
Cancer
Esanex Inc. 44
Early research (Phase 1)Looking for participantsNCT06670222
What this trial is testing

Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Low-risk Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 24
Early research (Phase 1)Ended earlyNCT07039929
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants

Who this might be right for
Healthy Participants
Incyte Corporation 24
Early research (Phase 1)Study completedNCT01015703
What this trial is testing

Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

Who this might be right for
Vaccine
BTG International Inc. 50
Early research (Phase 1)Study completedNCT05541861
What this trial is testing

Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 383
Early research (Phase 1)Enrolling By InvitationNCT07149454
What this trial is testing

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection

Who this might be right for
Tetanus
Lanzhou Institute of Biological Products Co., Ltd 68
Early research (Phase 1)Study completedNCT01365637
What this trial is testing

The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period.

Who this might be right for
Pain
Pfizer 30
Early research (Phase 1)Study completedNCT05561673
What this trial is testing

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Who this might be right for
Hepatitis B
GlaxoSmithKline 122
Testing effectiveness (Phase 2)Looking for participantsNCT06650566
What this trial is testing

Study of LM-299 in Subjects Advanced Malignant Tumors

Who this might be right for
Malignant Tumors
LaNova Medicines Limited 108
Early research (Phase 1)Looking for participantsNCT07484022
What this trial is testing

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Who this might be right for
Advanced Urothelial CancerMetastatic Urothelial Carcinoma
Generate Biomedicines 37
Early research (Phase 1)Study completedNCT01544322
What this trial is testing

Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors

Who this might be right for
Solid Tumors
MEI Pharma, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01410331
What this trial is testing

Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia

Who this might be right for
Critical Limb Ischemia
Juventas Therapeutics, Inc. 48
Early research (Phase 1)Looking for participantsNCT06687941
What this trial is testing

Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, HepatocellularCarcinoma, Non-Small-Cell Lung+1 more
Aptamer Sciences, Inc. 70
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Early research (Phase 1)Study completedNCT01391143
What this trial is testing

Safety Study of MGA271 in Refractory Cancer

Who this might be right for
Prostate CancerMelanomaRenal Cell Carcinoma+4 more
MacroGenics 179
Testing effectiveness (Phase 2)Study completedNCT01917825
What this trial is testing

The Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy

Who this might be right for
SciaticaLumbosacral Radiculopathy
Medtronic Spinal and Biologics 54
Early research (Phase 1)Study completedNCT02666196
What this trial is testing

A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects

Who this might be right for
Healthy
National University Hospital, Singapore 18
Next Page